New Data Reveals Metformin’s Role in Early Pregnancy Success – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Don’t Stop Metformin at a Positive Test: New Data Shows Continuing Through Trimester 1 Cut Miscarriage Risk in Half
A massive new systematic review and meta-analysis published in the American Journal of Obstetrics and Gynaecology analysed data from over 1,700 women to settle the debate on metformin timing. The results showed that continuing metformin through the first trimester significantly boosted clinical pregnancy rates and reduced the odds of miscarriage by over 50% compared to stopping immediately upon confirmation. Researchers propose that abrupt stopping causes a harmful ‘insulin rebound’ effect during critical early fetal development.
A systematic review and meta-analysis of 12 Randomized Controlled Trials (n=1,708) published in the American Journal of Obstetrics and Gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 21, 2026, 15:55Maha Alasiri: Early Diagnosis of Interstitial Ectopic Pregnancy
-
Jun 21, 2026, 15:51Fabian Laumer: AI-Assisted Detection of Deep Endometriosis
-
Jun 21, 2026, 15:48Alejandro González: What the Latest ESHRE 2025 Guidelines Tell Us on IVF Pretreatments
-
Jun 21, 2026, 15:43Expert Perspectives on Recurrent Pregnancy Loss and Family Support – ACOOG
-
Jun 21, 2026, 15:39Mili Thakur: Recurrent Pregnancy Loss Is A Signal to Investigate, Not to Stop
-
Jun 21, 2026, 15:30Barbara Lawrenz: Making Obesity Prevention Central to Reproductive Health and Reducing Pregnancy Loss
-
Jun 21, 2026, 15:27Ernesto Figueiro-Filho: Honoured to Receive the SOGC Regional Achievement Award at ACSC 2026
-
Jun 21, 2026, 14:54Meet Divya Kelath Shah in Our Latest Member Spotlight – ASRM
-
Jun 21, 2026, 14:48Mastering Interventional Ultrasound with Francesco D’Antonio – ISUOG